🟢 Roivant Sciences is trading 23.22% up in after-hours trading; catalyst remains unclear

Roivant Sciences is trading at $41.32, up 23.22%, with the after-hours catalyst unclear.

• No verified October 16 company-specific announcement surfaced to explain the surge; its latest indexed press release was dated October 7.
• Positive PHocus Phase 2 results announced September 8 are earlier context, not a confirmed catalyst for this move.
• The supplied market backdrop was negative and does not explain the sharp rise.